Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC test are performed for the diagnosis of cervical cancer. Increasing awareness regarding cervical cancer and increasing prevalence of cervical cancer in emerging economies are expected to drive growth of the market during the forecast period. For instance, according to the American Cancer Society, around 13,800 new cases of invasive cervical cancer were estimated to be diagnosed in the U.S. in 2020 and the disease was estimated to lead to death of 4,290 women in the same year.

The global cervical cancer diagnostic tests market is estimated to be valued at US$ 5,910.2 million in 2020 and is expected to exhibit a CAGR of 6.2 % over the forecast period (2020-2027).

Figure 1. Global Cervical Cancer Diagnostic Tests Market Share (%) in Terms of Value, By Region, 2020

Cervical Cancer Diagnostic Tests  | Coherent Market Insights

High prevalence of HPV infected patients and rising incidence of teenage sexual encounters are expected to drive the market growth over the forecast period

Human Papillomavirus (HPV) is the largest risk factor for cervical cancer. According to the World Health Organization, two types of HPV, HPV 16 and 18, cause approximately 70% of cervical cancers and pre-cancerous cervical lesions.

Also, according to the Centers for Disease Control and Prevention, 9 out of 10 cervical cancers are caused due to Human Papillomavirus (HPV) and around 11,000 cases of cervical cancer are caused by Human Papillomavirus (HPV) every year in the U.S.

Moreover, Human Papillomavirus (HPV) is majorly transmitted through sexual contact and cervical cancer is caused by certain types of HPV acquired through sexual contact.

A cross-sectional, multicentric, nationwide survey was conducted between September 2016 and November 2017 in Brazil to evaluate the prevalence of HPV infection in sexually active adolescents and young adults. According to the survey, the mean age of first sexual intercourse was 15.3 years in women and 14.9 years in men.

request-sample

Cervical Cancer Diagnostic Tests Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 5,910.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.2% 2027 Value Projection: US$ 9,010.4 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Test Type: Pap Smear Test, Colposcopy Test, ECC Test, HPV Test
  • By Age Group: Age 20 – 40, Age Above 40
Companies covered:

DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen

Growth Drivers:
  • Increasing prevalence of cervical cancer
  • High prevalence of human papillomavirus (HPV) infected patients and rising incidence of teenage sexual encounters
Restraints & Challenges:
  • Alternative cervical cancer diagnosis method
  • HPV vaccination

Figure 2. Global Cervical Cancer Diagnostic Tests Market Share (%), By Test Type, 2020

Cervical Cancer Diagnostic Tests  | Coherent Market Insights

Increasing prevalence of cervical cancer is expected to drive the market growth over the forecast period

For instance, according to the Cancer Research UK, around 3,152 new cases of cervical cancer were diagnosed during 2015 to 2017 in the U.K. and around 852 deaths were reported during the same time interval in the U.K.

Thus, increasing prevalence of cervical cancer is expected to drive the market growth over the forecast period.

Global Cervical Cancer Diagnostic Tests Market– Impact of Coronavirus (Covid-19) Pandemic

The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors. The private healthcare sector is one such sector which has been majorly impacted by the pandemic.

The lockdown in various countries due to the pandemic has placed an economic burden on the private healthcare sector. Healthcare providers are facing challenges with regards to declining outpatient visits, manpower, equipment, consumables, and other resources to ensure safety in treatment of patients with other diseases.

Moreover, the coronavirus pandemic has negatively impacted development, production, and supply of drugs and affected businesses of various companies operating in the healthcare sector across the globe. The pandemic has led to closure of industrial establishments, except manufacturing of essential commodities, and disruption in supply chain of products.

Thus, COVID-19 pandemic has affected the economy in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets.

Supply chain and manufacturing activities in India, China, U.S., and other countries have been disrupted due to lockdown while countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation of drugs and medical devices.

Thus, impact of the coronavirus (COVID-19) pandemic is expected to limit growth of the global cervical cancer diagnostic tests market during the forecast period.

Global Cervical Cancer Diagnostic Tests Market - Restraint

The major cervical cancer causing factor is HPV. Developments in the field of HPV vaccines and the vaccination of females in developed countries especially in the U.S., significantly reduces the chances of an HPV infection and hence, reduces the prevalence of cervical cancer, which is expected to hinder the market growth.

Moreover, increasing approvals of HPV vaccines by regulatory authorities is expected to hinder the growth of global cervical cancer diagnostic tests market.

For instance, in 2016, the China Food and Drug Administration (CFDA) approved Cervarix as the first HPV vaccine licensed for use in China against cervical cancer to meet the unmet needs of prevention of cervical cancers among Chinese population.

Key Players

Major players operating in the global cervical cancer diagnostic tests market include DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen.

Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed for the diagnosis of cervical cancer. Increasing product approvals along with increasing prevalence of cervical cancer in emerging economies are expected to assist the growth of the market during the forecast period. Furthermore, increasing awareness regarding cervical cancer in emerging economies and increasing funding for R&D in diagnosis of cervical cancer are expected to drive growth of the market during the forecast period.

Market Dynamics

The increasing prevalence of cervical cancer is expected to drive the global cervical cancer diagnostic tests market growth during the forecast period. For instance, according to the World Health Organization (WHO), around 570,000 new cases of cervical cancer were diagnosed globally in 2018.

Moreover, according to the World Cancer Research Fund International, cervical cancer is the fourth most common cancer in women. The table below provides the top 10 countries with highest rates of cervical cancer (according to the World Cancer Research Fund International) in 2018:

Rank

Country

Age Standardized Rate Per 100,000

1

Eswatini

75.3

2

Malawi

72.9

3

Zambia

66.4

4

Zimbabwe

62.3

5

Tanzania

59.1

6

Burundi

57.4

7

Uganda

54.8

8

Lesotho

52.1

9

Madagascar

51.6

10

Cosmos

50.9

Key features of the study:

  • This report provides in-depth analysis of the global cervical cancer diagnostic tests market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cervical cancer diagnostic tests market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cervical cancer diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical cancer diagnostic tests market

Detailed Segmentation:

  • Global Cervical Cancer Diagnostic Tests Market, By Test Type:
    • Pap Smear Test
    • Colposcopy Test
    • ECC Test
    • HPV Test
  • Global Cervical Cancer Diagnostic Tests Market, By Age Group:
    • Age 20 – 40
    • Age Above 40
  • Global Cervical Cancer Diagnostic Tests Market, By Region:
    • North America
      • By Test Type
        • Pap Smear Test
        • Colposcopy Test
        • ECC Test
        • HPV Test
      • By Age Group
        • Age 20 – 40
        • Age Above 40
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Test Type
        • Pap Smear Test
        • Colposcopy Test
        • ECC Test
        • HPV Test
      • By Age Group
        • Age 20 – 40
        • Age Above 40
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Test Type
        • Pap Smear Test
        • Colposcopy Test
        • ECC Test
        • HPV Test
      • By Age Group
        • Age 20 – 40
        • Age Above 40
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type
        • Pap Smear Test
        • Colposcopy Test
        • ECC Test
        • HPV Test
      • By Age Group
        • Age 20 – 40
        • Age Above 40
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Test Type
        • Pap Smear Test
        • Colposcopy Test
        • ECC Test
        • HPV Test
      • By Age Group
        • Age 20 – 40
        • Age Above 40
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type
        • Pap Smear Test
        • Colposcopy Test
        • ECC Test
        • HPV Test
      • By Age Group
        • Age 20 – 40
        • Age Above 40
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • DYSIS Medical Ltd. *
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • The Cooper Companies, Inc.
    • Danaher Corporation
    • Hoffmann-La Roche AG
    • Quest Diagnostics
    • Arbor Vita Corporation
    • Hologic, Inc.
    • Zilico Ltd
    • Qiagen

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Age Group
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • COVID19 Impact on Market
  4. Global Cervical Cancer Diagnostic Tests Market, By Test Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Pap Smear Test Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Colposcopy Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • ECC Procedures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Cervical Cancer Diagnostic Tests Market, By Age Group, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Age 20 - 40
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Age above 40
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Cervical Cancer Diagnostic Tests Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Guided Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Beckman Coulter Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 18 market data tables and 12 figures on “Cervical Cancer Diagnostic Tests Market - Global forecast to 2027”.

FAQgrowicon

Frequently Asked Questions

The Global Cervical Cancer Diagnostic Tests market size was valued at US$ 77.1 million in 2019 and is estimated to exhibit a CAGR of 2.4% between 2020 and 2027.
Colposcopy Procedure segment held the major market share in 2019 owing to an increasing prevalence of cervical cancer over the forecast period.
Major factor driving the growth of Global Cervical Cancer Diagnostic Tests market during the forecast period increasing prevalence of cervical cancer, and increasing adoption of at-home screening services.
Major factors hampering the growth of the Global Cervical Cancer Diagnostic Tests market during the forecast period constitutes of stringent regulations and guidelines.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Guided Therapeutics, Abbott Laboratories, Beckman Coulter Inc., and Becton, Dickinson and Company.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner